Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenal Suppression and PK of 122-0551 in Plaque Psoriasis
NCT01698333Phase 2Completed
- Start
- Apr 2012
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of halobetasol in plaque psoriasis. Started Apr 2012; status: completed.
02
Drugs
halobetasol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01698333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698333.